Mélanie Briand

926 total citations
35 papers, 648 citations indexed

About

Mélanie Briand is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mélanie Briand has authored 35 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mélanie Briand's work include Medical Imaging Techniques and Applications (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and MicroRNA in disease regulation (4 papers). Mélanie Briand is often cited by papers focused on Medical Imaging Techniques and Applications (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and MicroRNA in disease regulation (4 papers). Mélanie Briand collaborates with scholars based in France, Luxembourg and Canada. Mélanie Briand's co-authors include Pascal Gauduchon, Laurent Poulain, Pierre Lebailly, Yannick Lécluse, Sandrine Roulland, Marie-Hélène Louis, Nicolas Aide, Stéphanie Lheureux, Soizic Dutoit and Florence Giffard and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Mélanie Briand

35 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mélanie Briand France	16	274	194	139	115	87	35	648
Zebing Liu China	13	249 0.9×	125 0.6×	190 1.4×	113 1.0×	134 1.5×	38	514
Evdokia Arkoumani Greece	12	189 0.7×	129 0.7×	173 1.2×	91 0.8×	122 1.4×	21	481
Stephanie Petrillo Canada	18	394 1.4×	216 1.1×	293 2.1×	59 0.5×	118 1.4×	38	794
Ted Shih United States	6	201 0.7×	92 0.5×	222 1.6×	50 0.4×	86 1.0×	9	524
Magdalena Chechlińska Poland	15	246 0.9×	197 1.0×	370 2.7×	122 1.1×	113 1.3×	38	790
Chang-Hsien Lu Taiwan	11	159 0.6×	109 0.6×	174 1.3×	44 0.4×	79 0.9×	15	566
Masahiro Ohara Japan	16	193 0.7×	209 1.1×	299 2.2×	75 0.7×	106 1.2×	44	654
Linni Fan China	16	319 1.2×	186 1.0×	151 1.1×	128 1.1×	93 1.1×	50	649
Masafumi Inokuchi Japan	16	178 0.6×	210 1.1×	241 1.7×	135 1.2×	73 0.8×	61	663
Vamsi Parimi United States	17	375 1.4×	176 0.9×	279 2.0×	80 0.7×	240 2.8×	38	918

Countries citing papers authored by Mélanie Briand

Since Specialization

Citations

This map shows the geographic impact of Mélanie Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Briand more than expected).

Fields of papers citing papers by Mélanie Briand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Briand. The network helps show where Mélanie Briand may publish in the future.

Co-authorship network of co-authors of Mélanie Briand

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Briand. A scholar is included among the top collaborators of Mélanie Briand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Briand. Mélanie Briand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elie, Nicolas, Pierre‐Marie Morice, Louis‐Bastien Weiswald, et al.. (2025). Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids. Laboratory Investigation. 105(4). 104097–104097. 1 indexed citations

Wang, Zheni & Mélanie Briand. (2023). Understand the Changes in Motivation: Comparative Studies Using Theory-Based Interventions. Academy of Management Proceedings. 2023(1). 1 indexed citations

Aide, Nicolas, Laurent Poulain, Nicolas Elie, et al.. (2021). A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers. EJNMMI Research. 11(1). 11–11. 10 indexed citations

Bascetin, Rümeyza, Sabrina Kellouche, Franck Carreiras, et al.. (2018). Fibronectin amyloid-like aggregation alters its extracellular matrix incorporation and promotes a single and sparsed cell migration. Experimental Cell Research. 371(1). 104–121. 11 indexed citations

Brachet, Pierre-Emmanuel, Michel Fabbro, Alexandra Léary, et al.. (2017). A GINECO phase II study of Navitoclax (ABT 263) in women with platinum resistant/refractory recurrent ovarian cancer (ROC). Annals of Oncology. 28. v347–v347. 4 indexed citations

Lasnon, Charline, Audrey Emmanuelle Dugué, Mélanie Briand, Soizic Dutoit, & Nicolas Aide. (2015). Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?. EJNMMI Research. 5(1). 61–61. 11 indexed citations

Ollitrault, David, Florence Legendre, Mélanie Briand, et al.. (2014). BMP-2, Hypoxia, and COL1A1 / HtrA1 siRNAs Favor Neo-Cartilage Hyaline Matrix Formation in Chondrocytes. Tissue Engineering Part C Methods. 21(2). 133–147. 36 indexed citations

Villedieu, Marie, Émilie Brotin, Marie-Hélène Louis, et al.. (2014). PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced. Cancer Letters. 348(1-2). 38–49. 43 indexed citations

N’Diaye, Monique, Stéphanie Lheureux, Soizic Dutoit, et al.. (2013). Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis. APOPTOSIS. 18(4). 492–508. 35 indexed citations

10.

Lheureux, Stéphanie, Charlotte Lecerf, Mélanie Briand, et al.. (2013). 18F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer. Translational Oncology. 6(5). 586–IN7. 15 indexed citations

11.

Bohn, Pierre, Romain Modzelewski, Mélanie Briand, et al.. (2013). Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenografts. Nuclear Medicine Communications. 34(7). 709–717. 8 indexed citations

12.

Lasnon, Charline, et al.. (2013). Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4–2008 image quality parameters. EJNMMI Research. 3(1). 5–5. 7 indexed citations

13.

Lheureux, Stéphanie, Sophie Krieger, B. Weber, et al.. (2012). Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile. International Journal of Gynecological Cancer. 22(9). 1483–1488. 30 indexed citations

14.

Aide, Nicolas, Mélanie Briand, Pierre Bohn, et al.. (2010). αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study. European Journal of Nuclear Medicine and Molecular Imaging. 38(2). 323–333. 8 indexed citations

15.

Aide, Nicolas, Cédric Desmonts, Mélanie Briand, Matthieu Meryet‐Figuière, & Laurent Poulain. (2010). High-throughput small animal PET imaging in cancer research: evaluation of the capability of the Inveon scanner to image four mice simultaneously. Nuclear Medicine Communications. 31(10). 851–858. 15 indexed citations

16.

Chantepie, Sylvain, Dominique Vaur, Christoph Grunau, et al.. (2009). ZAP-70 intron1 DNA methylation status: Determination by pyrosequencing in B chronic lymphocytic leukemia. Leukemia Research. 34(6). 800–808. 18 indexed citations

17.

Aide, Nicolas, Laurent Poulain, Mélanie Briand, et al.. (2008). Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease. European Journal of Nuclear Medicine and Molecular Imaging. 36(3). 396–405. 18 indexed citations

18.

Villedieu, Marie, et al.. (2007). Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: Link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression. Gynecologic Oncology. 105(2). 373–384. 14 indexed citations

19.

Roulland, Sandrine, Pierre Lebailly, Mélanie Briand, et al.. (2003). BCL‐2/J_H translocation in peripheral blood lymphocytes of unexposed individuals: Lack of seasonal variations in frequency and molecular features. International Journal of Cancer. 104(6). 695–698. 12 indexed citations

20.

Briand, Mélanie, P. Pibarot, Jean G Dumesnil, & P Cartier. (2000). Midterm Echocardiographic Follow-Up After Ross Operation. Circulation. 102(Supplement 3). III–10. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact